Neogenomics, Inc. · NASDAQ:NEO
Tetrault Lynn A. sold 5,307 Neogenomics, Inc. shares (Form 4)
Traded Jun 9, 2026 · Filed Jun 11, 2026
On Jun 9, 2026, Tetrault Lynn A. (Director) sold 5,307 Neogenomics, Inc. shares at US$11.29 for US$59,916 under a trading plan, leaving 91,422 shares. Filed Jun 11, 2026 (Form 4).
- Sold
- 5,307 shares
- Price
- US$11.29
- Value
- US$59,916
- Holding after
- 91,422 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Common Stock | Sale | 5,307 | US$11.29 | 91,422 | Direct |
Source
Related
- Neogenomics, Inc.
- Tetrault Lynn A.
- Neogenomics, Inc. shareholders
- Form 4 · Tetrault Lynn A. · Jun 17, 2026
- Form 4 · Tetrault Lynn A. · Jun 3, 2026
- Form 4 · Stone Warren · Oct 5, 2026
- Form 4 · Olivo Alicia C · Sep 3, 2026
- Form 4 · Stone Warren · Aug 25, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Aug 14, 2026
- Form 4 · Aunan Greg D · Aug 6, 2026